Form 4 for PGNY Progyny, Inc.
Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-02 · accession 0001628280-23-008938 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-22 | 2023-03-02 | PGNY | Livingston Mark S. | CFO | A - Grant | $0.00 | +7,000 | 63.9K | +12% | $0 |
| D | 2023-03-22 | 2023-03-02 | PGNY | Livingston Mark S. | CFO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | A | A | 7,000 | $0.00 | 63,949 | D | — | — | (F1) Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on March 2, 2024, and the remaining RSUs vest in equal quarterly installments thereafter through March 2, 2027, subject to the Reporting Person continuing to provide service through each such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-02 | A | A | 20,000 | $0.00 | 20,000 | D | $36.23 · — to 2033-03-01 | 20,000 Common Stock | (F2) Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the Option vest on March 2, 2024, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through March 2, 2027, subject to the Reporting Person continuing to provide service through each such date. |